BBC vs. UTES
BBC (Virtus LifeSci Biotech Clinical Trials ETF) and UTES (Virtus Reaves Utilities ETF) are both exchange-traded funds - BBC is a Health & Biotech Equities fund tracking the LifeSci Biotechnology Clinical Trials Index, while UTES is a Utilities Equities fund actively managed by Virtus Investment Partners. BBC is passively managed, while UTES is actively managed. Over the past 10 years, BBC returned 7.60%/yr vs 12.51%/yr for UTES. At a 0.15 correlation, their price movements are largely independent. BBC charges 0.79%/yr vs 0.49%/yr for UTES.
Performance
BBC vs. UTES - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, BBC achieves a 8.17% return, which is significantly higher than UTES's 1.08% return. Over the past 10 years, BBC has underperformed UTES with an annualized return of 7.60%, while UTES has yielded a comparatively higher 12.51% annualized return.
BBC
- 1D
- -4.90%
- 1M
- -4.81%
- YTD
- 8.17%
- 6M
- 20.12%
- 1Y
- 123.11%
- 3Y*
- 19.82%
- 5Y*
- -2.05%
- 10Y*
- 7.60%
UTES
- 1D
- 2.05%
- 1M
- -4.89%
- YTD
- 1.08%
- 6M
- -1.15%
- 1Y
- 9.91%
- 3Y*
- 23.18%
- 5Y*
- 15.83%
- 10Y*
- 12.51%
BBC vs. UTES - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 8.17% | 63.77% | -1.11% | -1.80% | -35.13% | -22.31% | 30.32% | 63.81% | -18.29% | 57.85% |
UTES Virtus Reaves Utilities ETF | 1.08% | 25.71% | 45.35% | -2.46% | 0.80% | 20.74% | -0.30% | 25.48% | 5.14% | 14.21% |
Correlation
The correlation between BBC and UTES is 0.16, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.16 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.25 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.24 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.17 |
Correlation (All Time) Calculated using the full available price history since Sep 25, 2015 | 0.15 |
The correlation between BBC and UTES shifts across timeframes, from 0.15 (all time) to 0.25 (3 years), reflecting how their relationship changes across market environments.
BBC vs. UTES - Sectors Allocation Comparison
Sectors
BBC
UTES
Healthcare
-
Basic Materials
-
-
Communication Services
-
-
Consumer Cyclical
-
-
Consumer Defensive
-
-
Energy
-
-
Financial Services
-
-
Industrials
-
-
Real Estate
-
-
Technology
-
-
Utilities
-
Healthcare
BBC
UTES
-
Basic Materials
BBC
-
UTES
-
Communication Services
BBC
-
UTES
-
Consumer Cyclical
BBC
-
UTES
-
Consumer Defensive
BBC
-
UTES
-
Energy
BBC
-
UTES
-
Financial Services
BBC
-
UTES
-
Industrials
BBC
-
UTES
-
Real Estate
BBC
-
UTES
-
Technology
BBC
-
UTES
-
Utilities
BBC
-
UTES
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
BBC vs. UTES — Risk / Return Rank
BBC
UTES
BBC vs. UTES - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Virtus LifeSci Biotech Clinical Trials ETF (BBC) and Virtus Reaves Utilities ETF (UTES). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| BBC | UTES | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 3.49 | 0.47 | +3.02 |
Sortino ratioReturn per unit of downside risk | 4.11 | 0.77 | +3.34 |
Omega ratioGain probability vs. loss probability | 1.48 | 1.10 | +0.38 |
Calmar ratioReturn relative to maximum drawdown | 8.82 | 0.79 | +8.03 |
Martin ratioReturn relative to average drawdown | 28.55 | 1.82 | +26.73 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| BBC | UTES | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 3.49 | 0.47 | +3.02 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.05 | 0.77 | -0.83 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.20 | 0.62 | -0.42 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.12 | 0.70 | -0.59 |
Drawdowns
BBC vs. UTES - Drawdown Comparison
The maximum BBC drawdown since its inception was -76.85%, which is greater than UTES's maximum drawdown of -35.39%. Use the drawdown chart below to compare losses from any high point for BBC and UTES.
Loading charts...
Drawdown Indicators
| BBC | UTES | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -76.85% | -35.39% | -41.46% |
Max Drawdown (1Y)Largest decline over 1 year | -15.10% | -13.88% | -1.22% |
Max Drawdown (3Y)Largest decline over 3 years | -54.45% | -17.62% | -36.83% |
Max Drawdown (5Y)Largest decline over 5 years | -72.44% | -20.40% | -52.04% |
Max Drawdown (10Y)Largest decline over 10 years | -76.85% | -35.39% | -41.46% |
Current DrawdownCurrent decline from peak | -30.57% | -8.36% | -22.21% |
Average DrawdownAverage peak-to-trough decline | -37.14% | -5.52% | -31.62% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 4.66% | 6.05% | -1.39% |
Volatility
BBC vs. UTES - Volatility Comparison
Virtus LifeSci Biotech Clinical Trials ETF (BBC) has a higher volatility of 11.21% compared to Virtus Reaves Utilities ETF (UTES) at 7.44%. This indicates that BBC's price experiences larger fluctuations and is considered to be riskier than UTES based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| BBC | UTES | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 11.21% | 7.44% | +3.77% |
Volatility (6M)Calculated over the trailing 6-month period | 26.65% | 17.12% | +9.53% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.74% | 21.26% | +14.48% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 39.31% | 20.59% | +18.72% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 37.75% | 20.16% | +17.59% |
BBC vs. UTES - Expense Ratio Comparison
BBC has a 0.79% expense ratio, which is higher than UTES's 0.49% expense ratio.
Dividends
BBC vs. UTES - Dividend Comparison
BBC's dividend yield for the trailing twelve months is around 1.57%, more than UTES's 1.48% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
BBC Virtus LifeSci Biotech Clinical Trials ETF | 1.57% | 1.70% | 1.00% | 0.34% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 2.09% | 0.00% | 0.51% |
UTES Virtus Reaves Utilities ETF | 1.48% | 1.42% | 1.51% | 2.44% | 2.13% | 1.94% | 2.09% | 1.84% | 2.09% | 3.44% | 3.53% | 0.61% |
Frequently Asked Questions
BBC and UTES have a correlation of 0.16, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
BBC has higher volatility (11.21%) compared to UTES (7.44%). In terms of maximum drawdown, BBC dropped -76.85% vs UTES's -35.39%.
On 10-year performance, UTES leads with 12.51% vs 7.60% for BBC. On fees, UTES is cheaper at 0.49% per year. On volatility, UTES has been the lower-risk option at 7.44%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 10-year period, UTES has performed better with a 12.51% return vs 7.60%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
UTES is cheaper with a 0.49% expense ratio, compared with 0.79% for BBC.
BBC has the higher dividend yield at 1.57%, compared with 1.48% for UTES.
BBC is categorized as Health & Biotech Equities, while UTES is Utilities Equities. Their fees differ too: 0.79% for BBC and 0.49% for UTES.
BBC currently has the higher Sharpe Ratio (3.49 vs 0.47), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for BBC and UTES
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer